Kaletra Solution
NDC Package 0074-3956-46

11-digit billing NDC: 00074395646 · Billing unit: ML · 160 ML per package

Package Information

Kaletra (lopinavir and ritonavir) solution is kALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 14 days and older. This formulation utilizes a solution delivery system. Marketed by Abbvie Inc., this product is identified by NDC 0074-3956 and is authorized under FDA application NDA021251.

Identification & Billing

NDC Package Code
0074-3956-46
Package Description
1 BOTTLE in 1 CARTON / 160 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
00074395646
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
160 ML
RxNorm Crosswalk
  • RxCUI: 311369 - lopinavir 80 MG / ritonavir 20 MG in 1 mL Oral Solution
  • RxCUI: 311369 - lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution
  • RxCUI: 311369 - lopinavir 400 MG / ritonavir 100 MG per 5 ML Oral Solution
  • RxCUI: 311369 - lopinavir 80 MG / ritonavir 20 MG per 1 ML Oral Solution
  • RxCUI: 597730 - lopinavir 200 MG / ritonavir 50 MG Oral Tablet

Clinical Specifications

Proprietary Name
Kaletra
Non-Proprietary Name
Lopinavir And Ritonavir
Substance Name
Lopinavir; Ritonavir
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 14 days and older. Limitations of Use: Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA [see Microbiology (12.4)].

Regulatory & Marketing

Labeler Name
Abbvie Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA021251
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-18-2010
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0074-3956-46 identifies a specific commercial package of 1 bottle in 1 carton / 160 ml in 1 bottle of Kaletra, a human prescription drug labeled by Abbvie Inc.. This solution is formulated for oral use and contains lopinavir; ritonavir as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Abbvie Inc. on June 18, 2010. The current certification is valid through December 31, 2027.

How is this Abbvie Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074395646. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 160 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0074-3956-46
11-Digit CMS (5-4-2)
00074-3956-46

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.